Concepedia

Susumu Maruta

SM

Statistics

Publications

10

Citations

385

H-Index

10

Active since

2019

Affiliations

Chiba University(Current)

Chiba University Hospital

Asahi General Hospital

Juntendo University

Nihon University

Susumu Maruta is an author at Chiba University specializing in medicine, oncology, and cancer pharmacology.

Publications per year

2019–2023

10

Publications

10

Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan

Sadahisa Ogasawara, Yoshihiko Ooka, Norio Itokawa et al. · Investigational New Drugs · 2019 · 82 citations · Full text

, , +15

Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma

Susumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka et al. · Liver Cancer · 2020 · 80 citations · Full text

, , +13

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma

Hiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao et al. · Scientific Reports · 2021 · 41 citations · Full text

, , +16

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Keisuke Koroki, Naoya Kanogawa, Susumu Maruta et al. · Liver Cancer · 2021 · 40 citations · Full text

, , +13

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

Takahiro Maeda, Hiroaki Kanzaki, Tetsuhiro Chiba et al. · BMC Cancer · 2019 · 38 citations · Full text

, , +17

1–5 of 10